 Nemaura Medical Inc. NASDAQ: NMRD Nemaura, a medical technology company commercializing sugarBEAT, a non-invasive and flexible continuous glucose monitor CGM, together with BEATTMdiabetes, a health subscription service designed to help people with diabetes and pre-diabetes to better manage their condition through personalized lifestyle coaching, today provided a business update and on August 14, 2020 released financial results for the quarter ended June 30, 2020. 